Aryzta


Weak Q3 but better than feared

26/05/20 -"Weak, but better than expected Q3 thanks to North America. The strategic review and the massive pressure from a shareholder group led by the activist Veraison gave hope that the continuing ..."

Pages
39
Language
English
Published on
26/05/20
You may also be interested by these reports :
22/04/24
Improving momentum post the muted 1Q and still cheap

22/04/24
Muted start of the year as expected; guidance fully reiterated

19/04/24
It is too early to return to luxury tips. However, considering the current rock-bottom valuation level, positive news from the US or a hint of ...

19/04/24
The peer valuations have fallen since our last valuation update. The decline in our peer multiples-based valuation (mainly EV/EBITDA) has thus almost ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO